Agilon Health, Inc.
Agilon Health, Inc.（AGL）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · AGL · 截至 2026年6月8日
活动摘要
买入笔数
2
P-Purchase only
卖出笔数
0
近12个月
买卖比
∞
Buy/Sell (by trades)
整体情绪
Agilon Health, Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
AGL 季度内部人买卖趋势
AGL 内幕交易卖出 · AGL 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · AGL CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
AGL 高管卖出股份 · AGL 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Jun 1, 2026 | Zamore Denise Chief Legal Officer | Other | 485 | $45K | Form 4 |
| Jun 2, 2026 | Wulf John William Director | Award | 2,133 | — | Form 4 |
| Jun 2, 2026 | WILLIAMS RONALD A Director | Award | 2,133 | — | Form 4 |
| Jun 2, 2026 | McLoughlin Karen Director | Award | 2,133 | — | Form 4 |
| Jun 2, 2026 | MCKENZIE DIANA Director | Award | 2,133 | — | Form 4 |
| Jun 2, 2026 | Mansukani Sharad Director | Award | 2,133 | — | Form 4 |
| Jun 2, 2026 | Battaglia Silvana Director | Award | 2,133 | — | Form 4 |
| May 24, 2026 | Gertsch Timothy CAO | Other | 8 | $691 | Form 4 |
| May 7, 2026 | O'Rourke Timothy Patrick CEO & President · Director | Award | 200,000 | — | Form 4 |
| May 7, 2026 | O'Rourke Timothy Patrick CEO & President · Director | Award | 120,000 | — | Form 4 |
| Apr 14, 2026 | Zamore Denise Chief Legal Officer | Other | 20 | $454 | Form 4 |
| Apr 15, 2026 | Zamore Denise Chief Legal Officer | Other | 220 | $6K | Form 4 |
| Apr 14, 2026 | Venkatachaliah Girish CTO | Other | 96 | $2K | Form 4 |
| Apr 15, 2026 | Venkatachaliah Girish CTO | Other | 330 | $9K | Form 4 |
| Apr 14, 2026 | Gertsch Timothy CAO | Other | 25 | $567 | Form 4 |
| Apr 15, 2026 | Gertsch Timothy CAO | Other | 122 | $3K | Form 4 |
| Apr 14, 2026 | Shaker Benjamin Chief Markets Officer | Other | 104 | $2K | Form 4 |
| Apr 15, 2026 | Shaker Benjamin Chief Markets Officer | Other | 571 | $15K | Form 4 |
| Apr 1, 2026 | Schwaneke Jeffrey A. CFO | Award | 75,000 | — | Form 4 |
| Apr 1, 2026 | Schwaneke Jeffrey A. CFO | Other | 1,662 | $16K | Form 4 |
| Apr 1, 2026 | Shaker Benjamin Chief Markets Officer | Award | 70,000 | — | Form 4 |
| Apr 1, 2026 | Shaker Benjamin Chief Markets Officer | Other | 1,664 | $16K | Form 4 |
| Apr 1, 2026 | Gertsch Timothy CAO | Award | 10,000 | — | Form 4 |
| Apr 1, 2026 | Gertsch Timothy CAO | Other | 266 | $3K | Form 4 |
| Apr 1, 2026 | Venkatachaliah Girish CTO | Award | 28,000 | — | Form 4 |
O'Rourke Timothy Patrick
CEO & President · Director
日期
May 7
股数
200,000
均价
—
总金额
—
O'Rourke Timothy Patrick
CEO & President · Director
日期
May 7
股数
120,000
均价
—
总金额
—
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 AGL 内幕交易
AGL 内幕交易
Agilon Health, Inc.（AGL）内幕交易数据来源于公司内部人（包括Zamore Denise (Chief Legal Officer), Gertsch Timothy (CAO), Shaker Benjamin (Chief Markets Officer)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。AGL内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Agilon Health, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
AGL 内幕交易 · 5个问题Agilon Health, Inc.（AGL）的内部人包括高管和董事，如Zamore Denise (Chief Legal Officer), Gertsch Timothy (CAO), Shaker Benjamin (Chief Markets Officer)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026